Dashboard
Manage Tickers

LYRALyra Therapeutics, Inc.

Nasdaq lyratherapeutics.com


$ 0.38 $ -0.01 (-3.62 %)    

Friday, 10-May-2024 15:59:46 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 0.3725
$ 0.38
$ 0.00 x 0
$ 0.00 x 0
$ 0.36 - $ 0.38
$ 0.36 - $ 6.79
3,680,139
na
23.84M
$ 0.70
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2024 03-31-2024 10-Q
2 03-22-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-29-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-09-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-11-2021 03-31-2021 10-Q
14 03-09-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-28-2020 03-31-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
05/07/2024 16:31:17

where-lyra-therapeutics-stands-with-analysts
Where Lyra Therapeutics Stands With Analysts
05/07/2024 15:00:16

hc-wainwright--co-downgrades-lyra-therapeutics-to-neutral-announces-2-price-target
HC Wainwright & Co. Downgrades Lyra Therap...
05/07/2024 13:48:16

HC Wainwright & Co. analyst Matthew Caufield downgrades Lyra Therapeutics (NASDAQ:LYRA) from Buy to Neutral and announce...

jefferies-downgrades-lyra-therapeutics-to-hold-lowers-price-target-to-05
Jefferies Downgrades Lyra Therapeutics to ...
05/07/2024 12:04:40

Jefferies analyst Dennis Ding downgrades Lyra Therapeutics (NASDAQ:LYRA) from Buy to Hold and lowers the price target from $...

dow-surges-over-100-points-eyepoint-pharmaceuticals-shares-plunge
Dow Surges Over 100 Points; EyePoint Pharm...
05/06/2024 19:04:00

crude-oil-gains-1-treehouse-foods-shares-fall-after-q1-results
Crude Oil Gains 1%; TreeHouse Foods Shares...
05/06/2024 16:48:16

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
05/06/2024 16:31:16

btig-downgrades-lyra-therapeutics-to-neutral
BTIG Downgrades Lyra Therapeutics to Neutral
05/06/2024 15:58:49

BTIG analyst Justin Zelin downgrades Lyra Therapeutics (NASDAQ:LYRA) from Buy to Neutral.

nasdaq-jumps-100-points-tyson-foods-sales-miss-views
Nasdaq Jumps 100 Points; Tyson Foods Sales...
05/06/2024 15:14:07

why-lyra-therapeutics-stock-is-down-93-today
Why Lyra Therapeutics Stock Is Down 93% Today
05/06/2024 13:25:04

Lyra Therapeutics shares are trading lower by 93% to $0.30 during Monday's session. The company announced the ENLIGHTEN 1 t...

lyra-therapeutics-shares-resume-trade
Lyra Therapeutics Shares Resume Trade
05/06/2024 12:30:25

trading-halt-halt-status-updated-at-82500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:25:...
05/06/2024 12:25:04

lyra-therapeutics-reports-topline-results-from-phase-3-enlighten-1-trial-for-lyr-210-in-chronic-rhinosinusitis-enlighten-1-trial-did-not-meet-its-primary-endpoint-company-plans-to-evaluate-full-dataset-and-path-forward
Lyra Therapeutics Reports Topline Results ...
05/06/2024 12:01:14

ENLIGHTEN 1 trial did not meet its primary endpoint Company plans to evaluate full dataset and path forwardWATERTOWN, Mass., Ma...

trading-halt-halted-at-75000-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 a.m. ET - ...
05/06/2024 11:50:04

hc-wainwright--co-reiterates-buy-on-lyra-therapeutics-maintains-12-price-target
HC Wainwright & Co. Reiterates Buy on Lyra...
05/01/2024 10:31:10

HC Wainwright & Co. analyst Matthew Caufield reiterates Lyra Therapeutics (NASDAQ:LYRA) with a Buy and maintains $12 pri...

lyra-therapeutics-q1-eps-035-misses-026-estimate-sales-53200k-beat-42000k-estimate
Lyra Therapeutics Q1 EPS $(0.35) Misses $(...
04/30/2024 20:33:30

Lyra Therapeutics (NASDAQ:LYRA) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $...

cantor-fitzgerald-reiterates-overweight-on-lyra-therapeutics
Cantor Fitzgerald Reiterates Overweight on...
04/17/2024 13:36:02

Cantor Fitzgerald analyst Louise Chen reiterates Lyra Therapeutics (NASDAQ:LYRA) with a Overweight.

b-of-a-securities-maintains-buy-on-lyra-therapeutics-lowers-price-target-to-11
B of A Securities Maintains Buy on Lyra Th...
03/25/2024 10:47:11

B of A Securities analyst Jason Gerberry maintains Lyra Therapeutics (NASDAQ:LYRA) with a Buy and lowers the price target fr...

hc-wainwright--co-reiterates-buy-on-lyra-therapeutics-maintains-12-price-target
HC Wainwright & Co. Reiterates Buy on Lyra...
03/22/2024 10:40:29

HC Wainwright & Co. analyst Matthew Caufield reiterates Lyra Therapeutics (NASDAQ:LYRA) with a Buy and maintains $12 pri...

what-4-analyst-ratings-have-to-say-about-lyra-therapeutics
What 4 Analyst Ratings Have To Say About L...
10/06/2023 15:00:49

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION